Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPINALON for Chronic Spinal Cord Injury
NCT01484184Phase 2Completed
- Sponsor
- Nordic Life Science Pipeline
- Start
- Jul 2013
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levodopa, carbidopa, buspirone in spinal cord injury (SCI), sponsored by Nordic Life Science Pipeline. Started Jul 2013; status: completed.
02
Drugs
levodopacarbidopabuspirone
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT01484184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01484184.